{
    "Trade/Device Name(s)": [
        "ARCHITECT i Theophylline",
        "ARCHITECT i Theophylline Immunoassay",
        "ARCHITECT i Theophylline Calibrators (A-F)"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K070810",
    "Predicate Device Reference 510(k) Number(s)": [
        "K953016"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LGS",
        "DLJ"
    ],
    "Summary Letter Date": "March 23, 2007",
    "Summary Letter Received Date": "March 27, 2007",
    "Submission Date": "March 20, 2007",
    "Regulation Number(s)": [
        "21CFR862.3880",
        "21CFR862.3200"
    ],
    "Regulation Name(s)": [
        "Theophylline test system",
        "Calibrator, Drug Specific"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology"
    ],
    "Analyte(s)": [
        "Theophylline"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT i Theophylline immunoassay and calibrators for quantitative measurement of theophylline in serum or plasma using CMIA technology",
    "Indications for Use Summary": "For quantitative measurement of theophylline in human serum or plasma for diagnosis and treatment of overdose or monitoring therapy; calibrators for calibration of the ARCHITECT i System.",
    "fda_folder": "Toxicology"
}